Tiffany Le
Principal·New Enterprise Associates
Tiffany Le is a Principal at NEA investing in life sciences, with a focus on medtech, healthtech, and companies at the intersection of technology and medicine. She serves as a Board Director for Allay Therapeutics, Amber Therapeutics, FIRE1, Magenta Medical, Revelle Aesthetics, and ExploraMed, and works with Moximed, Setpoint Medical, and Willow. Before NEA, she held roles at Kaiser Permanente Ventures and L.E.K. Consulting.
See the rest of Tiffany Le's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.